Home » Biopharma and Life Sciences » Diagnostic Electrocardiograph (ECG) Market Report 2030

Diagnostic Electrocardiograph (ECG) Market By Product (Resting ECG, Stress ECG, Holter Monitors, Event Monitors, Implantable Loop Recorders, MCT, Smart Wearables, Software & Services); By Lead Configuration (12-Lead, 6-Lead, 5-Lead, 3-Lead, Single-Lead); By End-User (Hospitals & Clinics, Home Care, Ambulatory); By Connectivity (Wireless, Wired); By Region, Device & Monitoring Service Revenue Economics, 2025–2030

Published On: Oct-2025   |   Base Year: 2025   |   No Of Pages: 150   |   Historical Data: 2021-2024   |   Formats: Interactive Web Dashboard   |   Report ID: PMI-38553168

Diagnostic Electrocardiograph (ECG) Market Size & Trends

The global diagnostic electrocardiograph (ECG) market is projected to experience steady growth over the forecast period. Rising incidences of cardiovascular diseases and lifestyle-related conditions such as ischemic heart disease (IHD), hypertensive heart disease, stroke, and peripheral artery disease are expected to be the primary growth drivers.

Additional factors supporting market expansion include:

  • The increasing geriatric population base
  • Improved healthcare infrastructure
  • Supportive reimbursement frameworks

Moreover, technological advancements in ECG devices, combined with the introduction of remote monitoring solutions, are anticipated to further accelerate adoption.

While markets in developed nations are approaching saturation, developing economies present significant growth opportunities due to:

  • Favorable government policies
  • Rising healthcare expenditure
  • Large untapped patient populations

 

Market Segmentation

The global diagnostic ECG market is segmented by product type, lead type, and end use.

By Product Type

  • Holter Monitors
  • Resting ECG Systems
  • Stress ECG Monitors

In 2014, Holter monitors represented the largest segment, driven by the expansion of hospital networks and increased hospital expenditure on ECG devices.

By Lead Type

  • Single-lead ECG Devices
  • 3–6 Lead ECG Devices
  • 12-lead ECG Devices
  • Other Lead Types

In 2014, the 3–6 lead ECG devices segment dominated the market, attributed to their high efficiency at relatively low cost, and is expected to maintain a strong growth trajectory.

By End Use

  • Hospitals
  • Clinics
  • Ambulatory Settings
  • Other Institutions

In 2014, the hospital segment led the market, supported by the rapid increase in hospital establishments and significant capital allocation for ECG equipment.

 

Regional Insights

The global diagnostic ECG market is analyzed across North America, Asia Pacific, Latin America, Europe, and the Middle East & Africa (MEA).

  • North America:
    In 2014, North America held the largest revenue share. Factors such as a growing geriatric population, rising demand for minimally invasive procedures, and high per-capita income are expected to sustain regional dominance throughout the forecast period.
  • Europe:
    By 2022, market growth in Europe is anticipated to slow down due to saturation.
  • Asia Pacific:
    Including India, Japan, China, Myanmar, Brazil, and other Asian countries, this region is projected to record lucrative growth. Key drivers include increasing disposable income, a large population base, and improving healthcare infrastructure.

 

 

Diagnostic Electrocardiograph Market Competitive Landscape Analysis

The market is extremely fragmented, with numerous important competitors. Companies focus on large partnerships, mergers, and acquisitions to increase their market share. Market participants are also working on research and development to increase product quality, reduce manufacturing costs, and design better devices to promote patient compliance and safety.

 

To maintain market position, firms actively pursue business development strategies such as mergers, acquisitions, and strategic collaborations.

 

Recent Developments

  • In March 2022, GE Healthcare announced its partnership with AliveCor. Medical professionals can access GE Healthcare’s MUSE system using the KardiaMobile 6L ECG device. The partnership aims to increase patient convenience and reduce cardio-based hospitalizations by improving the patient’s data quality and integration.

 

  • In January 2022, Koninklijke Philips introduced a first-at-home, 12-lead ECG integrated solution for decentralized clinical trials. Koninklijke Philips aims to improve patient retention, compliance, and trial by introducing a new system to reduce the need and burden for clinical trials.

 

  • In December 2021, Baxter International, Inc. announced the acquisition of Hillrom for USD 12.5 billion. The Hillrom acquisition ushers in the next chapter of Baxter’s transformation, bringing a new wave of promise to deliver greater impact for patients, clinicians, workers, shareholders, and other communities the firm serves worldwide.

 

  • In July 2021, Medtronic announced FDA clearance for two of its AccuRhythm™ AI Algorithms with the LINQ II™ insertable cardiac monitor. Applying AccuRhythm AI to LINQ II data is a key ICM breakthrough, allowing Medtronic to decrease clinical inefficiencies caused by false alarms and assist physicians in better identifying and focusing on the relevant data they require to treat their patients.

 

  • In February 2021, Koninklijke Philips NV announced its acquisition of Biotelemetry, Inc. The acquisition of BioTelemetry fits well with Philips’ cardiac care portfolio and its strategy to enhance care delivery throughout the health continuum with integrated solutions.

 

List of Diagnostic Electrocardiographs that Key Market Leaders Develop:

Product

Function

Key Player

ECG-3150

Identification of arrhythmia

Nihon Kohden

Electrocardiograph CardiMax FX-8400

Identification of the presence of acute myocardial infarction.

Fukuda Denshi

GE ECG Machine Mac 2000

Fast and Accurate Diagnosis of Cardiac issues.

GE Healthcare

Philips ECG Machine PageWriter TC50

A better interpretation of rhythm and morphology for pediatric and adult patients.

Koninklijke Philips NV

Suzuken Cardy 302 MAX Waterproof Holter ECG recorder

Wearable Holter recorder.

Suzuken Co. Ltd.

.

1.   Introduction

       1.1. Study Objective

       1.2. Market Definition        

       1.3. Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1. Data Procurement

       2.2. Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

   2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3. Market Size Estimation

       2.4. Bottom-Up and Top-Down Approaches

              2.4.1.     Bottom-Up Approach

                     2.4.1.1.         Approach for arriving at Market size by bottom-up analysis

              2.4.2.     Top-Down Approach

                     2.4.2.1.         Approach for Capturing Market Size by Top-Down Analysis

       2.5. Market Breakdown and Data Triangulation

       2.6. Research Methodology

       2.7. Risk Assessment

3.  Executive Summary

       3.1 Diagnostic Electrocardiograph Market: Post-Covid-19

              3.1.1      Actual Scenario

              3.1.2      Pessimistic Scenario

              3.1.3      Optimistic Scenario

              3.1.4      Market Summary

4. Industry Outlook

       4.1 Market Snapshot

       4.2 Diagnostic Electrocardiograph Market

              4.2.1       Market, 2021 – 2030 (USD Million)

       4.3 Regional Business Analysis

              4.3.1       Market, by region, 2021-2030 (USD Million)

       4.4 By Product Type Business Analysis

              4.4.1       Market, By Product Type, 2021-2030 (USD Million)

       4.5 By End-User Business Analysis

              4.5.1       Market, By End-User, 2021-2030 (USD Million)

       4.6 Lead Type Business Analysis

              4.6.1       Market, By Lead Type, 2021-2030 (USD Million)

       4.7 Value Chain Analysis

       4.8 Market Variable Analysis

              4.8.1      Market Drivers Analysis

              4.8.2      Market Restraints Analysis

       4.9Business Environment Analysis Tool

              4.9.1      Market PEST analysis

              4.9.2      Market Porter’s analysis

       4.10Penetration & Growth Prospect Mapping

5. Market Dynamics

       5.1. Introduction

       5.2. Market Dynamics

              5.2.1.     Drivers

              5.2.2.     Restraints

              5.2.3.     Opportunities

              5.2.4.     Challenges

       5.3. Impact of Covid-19 On Market

       5.4. Value Chain Analysis

       5.5. Ecosystem

       5.6. Patent Analysis

       5.7. Trade Analysis

       5.8. Tariff Analysis

       5.9. Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1    Threat of New Entrants

              5.10.2    Threat of Substitutes

              5.10.3    Bargaining Power of Buyers

              5.10.4    Bargaining Power of Suppliers

              5.10.5    Degree of Competition

       5.11.              Lead Type Analysis

              5.11.1.   Trends in Lead Type (2014-2020)

              5.11.2.   Trends in Lead Type (2021-2028)

       5.12.              Pricing Analysis

              5.12.1.   Average Price Trend Analysis (By Region, By Countries)

6. Competitive & Vendor Landscape

       6.1. Company Market Share Analysis

       6.2. Manufacturers Manufacturing Sites, Area Served, Product Type

       6.3. Market Competitive Situation and Trends

       6.4. Manufacturers Mergers & Acquisitions, Expansion Plans

7. Market: By Product Type Segment Analysis

       7.1. Introduction

       7.2. Sales Volume & Revenue Analysis (2021-2030)

       7.3. Product

              7.3.1. Product, 2021-2030 (USD Million)

                    7.3.1. Resting ECG Devices, 2021-2030 (USD Million)

                    7.3.1. Stress ECG Devices, 2021-2030 (USD Million)

                    7.3.1. Holter Monitors, 2021-2030 (USD Million)

                    7.3.1. Implantable Loop Recorders, 2021-2030 (USD Million)

                    7.3.1. Event Monitors, 2021-2030 (USD Million)

                    7.3.1. MCT Devices, 2021-2030 (USD Million)

                    7.3.1. Smart ECG Monitors, 2021-2030 (USD Million)

 7.4. Software and Service

              7.4.1. Software and Service Market, 2021-2030 (USD Million)

8.   Market: By End-User Segment Analysis

       8.1. Introduction

       8.2. Sales Volume & Revenue Analysis (2021-2030)

       8.3. Hospitals & Clinics

              8.3.1.     Hospitals & Clinics Market, 2021-2030 (USD Million)

       8.4. Home

              8.4.1.     Home Market, 2021-2030 (USD Million)

       8.5. Ambulatory Care

              8.5.1.     Ambulatory Care Market, 2021-2030 (USD Million)

9.   Market: By Lead Type Segment Analysis

       9.1. Introduction

       9.2. Sales Volume & Revenue Analysis (2021-2030)

       9.3. 12-lead

              9.3.1.     12-lead Market, 2021-2030 (USD Million)

       9.4. 5-lead

              9.4.1.     5-lead Market, 2021-2030 (USD Million)

       9.5. 3-lead

              9.5.1.     3-lead Market, 2021-2030 (USD Million)

       9.5. 6-lead

              9.5.1.     6-lead Market, 2021-2030 (USD Million)

       9.5. Single-lead

              9.5.1.     Single-lead Market, 2021-2030 (USD Million)

       9.5. Other Lead Types

              9.5.1.     Other Lead Types Market, 2021-2030 (USD Million)

10.   Market: Regional Outlook

10.1 North America

              10.1.1.   North America Market, By Product Type, 2021-2030 (USD Million)

              10.1.2.   North America Market, By End-User, 2021-2030 (USD Million)

              10.1.3.   North America Market, by Lead Type, 2021-2030 (USD Million)

              10.1.4.   North America Market, by Country, 2021-2030 (USD Million)

       10.1.4.1. U.S.

                     10.1.4.1.1.   U.S.  Market, By Product Type, 2021-2030 (USD Million)

                     10.1.4.1.2.   U.S.  Market, By End-User, 2021-2030 (USD Million)

                     10.1.4.1.3.   U.S.  Market, by Lead Type, 2021-2030 (USD Million)

10.1.4.2. Canada

                     10.1.4.2.1.   Canada Market, By Product Type, 2021-2030 (USD Million)

                     10.1.4.2.2.   Canada Market, By End-User, 2021-2030 (USD Million)

                     10.1.4.2.3.   Canada Market, by Lead Type, 2021-2030 (USD Million)

10.2. Europe

              10.2.1.   Europe Market, By Product Type, 2021-2030 (USD Million)

              10.2.2.   Europe Market, By End-User, 2021-2030 (USD Million)

              10.2.3.   Europe Market, by Lead Type, 2021-2030 (USD Million)

              10.2.4.   Europe Market, by country, 2021-2030 (USD Million)

10.2.4.1    U.K.

                     10.2.4.1.1.   U.K.  Market, By Product Type, 2021-2030 (USD Million)

                     10.2.4.1.2.   U.K.  Market, By End-User, 2021-2030 (USD Million)

                     10.2.4.1.3.   U.K.  Market, by Lead Type, 2021-2030 (USD Million)

10.2.4.2.              Germany

                     10.2.4.2.1.   Germany Market, By Product Type, 2021-2030 (USD Million)

                     10.2.4.2.2.   Germany Market, By End-User, 2021-2030 (USD Million)

                     10.2.4.2.3.   Germany Market, by Lead Type, 2021-2030 (USD Million)

10.2.4.3.              France

                     10.2.4.3.1.   France Market, By Product Type, 2021-2030 (USD Million)

                     10.2.4.3.2.   France Market, By End-User, 2021-2030 (USD Million)

                     10.2.4.3.3.   France Market, by Lead Type, 2021-2030 (USD Million)

10.2.4.4.              Rest of Europe

                     10.2.4.4.1.   Rest of Europe Market, By Product Type, 2021-2030 (USD Million)

                     10.2.4.4.2.   Rest of Europe Market, By End-User, 2021-2030 (USD Million)

                     10.2.4.4.3.   Rest of Europe Market, by Lead Type, 2021-2030 (USD Million)

       10.3.              Asia Pacific

              10.3.1.   Asia Pacific Market, By Product Type, 2021-2030 (USD Million)

              10.3.2.   Asia Pacific Market, By End-User, 2021-2030 (USD Million)

              10.3.3.   Asia Pacific Market, by Lead Type, 2021-2030 (USD Million)

              10.3.4.   Asia Pacific Market, by country, 2021-2030 (USD Million)

10.3.4.1.              China

                     10.3.4.1.1.   China Market, By Product Type, 2021-2030 (USD Million)

                     10.3.4.1.2.   China Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.1.3.   China Market, by Lead Type, 2021-2030 (USD Million)

10.3.4.2.              India

                     10.3.4.2.1.   India Market, By Product Type, 2021-2030 (USD Million)

                     10.3.4.2.2.   India Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.2.3.   India Market, by Lead Type, 2021-2030 (USD Million)

10.3.4.3.              Japan

                     10.3.4.3.1.   Japan Market, By Product Type, 2021-2030 (USD Million)

                     10.3.4.3.2.   Japan Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.3.3.   Japan Market, by Lead Type, 2021-2030 (USD Million)

10.3.4.4.              South Korea

                     10.3.4.4.1.   South Korea Market, By Product Type, 2021-2030 (USD Million)

                     10.3.4.4.2.   South Korea Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.4.3.   South Korea Market, by Lead Type, 2021-2030 (USD Million)

10.3.4.5.              Rest of ASIA PACIFIC

                     10.3.4.5.1.   Rest of ASIA PACIFIC Market, By Product Type, 2021-2030 (USD Million)

                     10.3.4.5.2.   Rest of ASIA PACIFIC Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.5.3.   Rest of ASIA PACIFIC Market, by Lead Type, 2021-2030 (USD Million)

       10.4.              Latin America

              10.4.1.   Latin America Market, By Product Type, 2021-2030 (USD Million)

              10.4.2.   Latin America Market, By End-User, 2021-2030 (USD Million)

              10.4.3.   Latin America Market, by Lead Type, 2021-2030 (USD Million)

              10.4.4.   Latin America Market, by country, 2021-2030 (USD Million)

10.4.4.1.              Brazil

                     10.4.4.1.1.   Brazil Market, By Product Type, 2021-2030 (USD Million)

                     10.4.4.1.2.   Brazil Market, By End-User, 2021-2030 (USD Million)

                     10.4.4.1.3.   Brazil Market, by Lead Type, 2021-2030 (USD Million)

10.4.4.2.              Mexico

                     10.4.4.2.1.   Mexico Market, By Product Type, 2021-2030 (USD Million)

                     10.4.4.2.2.   Mexico Market, By End-User, 2021-2030 (USD Million)

                     10.4.4.2.3.   Mexico Market, by Lead Type, 2021-2030 (USD Million)

                     10.4.4.3.       Rest of Latin America

                     10.4.4.3.1.   Rest of the Latin America Market, By Product Type, 2021-2030 (USD Million)

                     10.4.4.3.2.   Rest of the Latin America Market, By End-User, 2021-2030 (USD Million)

                     10.4.4.3.3.   Rest of the Latin America Market, by Lead Type, 2021-2030 (USD Million)

       10.5.              MEA

              10.5.1.   MEA Market, By Product Type, 2021-2030 (USD Million)

              10.5.2.   MEA Market, By End-User, 2021-2030 (USD Million)

              10.5.3.   MEA Market, by Lead Type, 2021-2030 (USD Million)

              10.5.4.   MEA Market, by Region, 2021-2030 (USD Million)

 

11. Competitive Landscape

11.1 GE Healthcare

              11.1.1.   Company overview

              11.1.2.   Financial performance

              11.1.3.   Product Portfolio Analysis

              11.1.4.   Business Strategy & Recent Development

11.2. Nihon Kohden Corporation

              11.2.1.   Company overview

              11.2.2.   Financial performance

              11.2.3.   Product Portfolio Analysis

              11.2.4.   Business Strategy & Recent Development

11.3. Koninklijke Philips NV

              11.3.1.   Company overview

              11.3.2.   Financial performance

              11.3.3.   Product Portfolio Analysis

              11.3.4.   Business Strategy & Recent Development

11.4. HEYER MEDICAL AG

              11.4.1.   Company overview

              11.4.2.   Financial performance

              11.4.3.   Product Portfolio Analysis

              11.4.4.   Business Strategy & Recent Development

11.5. Hill-Rom Holdings

              11.5.1.   Company overview

              11.5.2.   Financial performance

              11.5.3.   Product Portfolio Analysis

              11.5.4.   Business Strategy & Recent Development

11.6. SCHILLER

              11.6.1.   Company overview

              11.6.2.   Financial performance

              11.6.3.   Product Portfolio Analysis

              11.6.4.   Business Strategy & Recent Development

11.7. BPL Medical Technologies

              11.7.1.   Company overview

              11.7.2.   Financial performance

              11.7.3.   Product Portfolio Analysis

              11.7.4.   Business Strategy & Recent Development

11.8. ACS Diagnostics

              11.8.1.   Company overview

              11.8.2.   Financial performance

              11.8.3.   Product Portfolio Analysis

              11.8.4.   Business Strategy & Recent Development

11.9. BTL

              11.9.1.   Company overview

              11.9.2.   Financial performance

              11.9.3.   Product Portfolio Analysis

              11.9.4.   Business Strategy & Recent Development

11.10. Allengers Medical Systems, Ltd

              11.10.1. Company overview

              11.10.2. Financial performance

              11.10.3. Product Portfolio Analysis

              11.10.4. Business Strategy & Recent Development

11.11. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS Co., Ltd

              11.11.1. Company overview

              11.11.2. Financial performance

              11.11.3. Product Portfolio Analysis

              11.11.4. Business Strategy & Recent Development

11.12. FUKUDA DENSHI

              11.12.1. Company overview

              11.12.2. Financial performance

              11.12.3. Product Portfolio Analysis

              11.12.4. Business Strategy & Recent Development

11.13. Innomed Medical

              11.13.1. Company overview

              11.13.2. Financial performance

              11.13.3. Product Portfolio Analysis

              11.13.4. Business Strategy & Recent Development

11.14. Edan Instruments, Inc

              11.14.1. Company overview

              11.14.2. Financial performance

              11.14.3. Product Portfolio Analysis

              11.14.4. Business Strategy & Recent Development

11.15. Cardioline SpA

              11.15.1. Company overview

              11.15.2. Financial performance

              11.15.3. Product Portfolio Analysis

              11.15.4. Business Strategy & Recent Development

 11.16. Eccosur

              11.16.1. Company overview

              11.16.2. Financial performance

              11.16.3. Product Portfolio Analysis

              11.16.4. Business Strategy & Recent Development

11.17. Suzuken Co. Ltd

              11.17.1. Company overview

              11.17.2. Financial performance

              11.17.3. Product Portfolio Analysis

              11.17.4. Business Strategy & Recent Development

11.18. Norav Medical

              11.18.1. Company overview

              11.18.2. Financial performance

              11.18.3. Product Portfolio Analysis

              11.18.4. Business Strategy & Recent Development

11.19. VectraCor, Inc

              11.19.1. Company overview

              11.19.2. Financial performance

              11.19.3. Product Portfolio Analysis

              11.19.4. Business Strategy & Recent Development

11.20. Bionet Co., Ltd

              11.20.1. Company overview

              11.20.2. Financial performance

              11.20.3. Product Portfolio Analysis

              11.20.4. Business Strategy & Recent Development

11.21. Nexus Lifecare

              11.21.1. Company overview

              11.21.2. Financial performance

              11.21.3. Product Portfolio Analysis

              11.21.4. Business Strategy & Recent Development

11.22. Midmark Corporation

              11.22.1. Company overview

              11.22.2. Financial performance

              11.22.3. Product Portfolio Analysis

              11.22.4. Business Strategy & Recent Development

11.23. OSI Systems, Inc

              11.23.1. Company overview

              11.23.2. Financial performance

              11.23.3. Product Portfolio Analysis

              11.23.4. Business Strategy & Recent Development

 

List of Tables (86 Tables)

TABLE 1.   Market, By Product Type, 2021-2030 (USD Million)

TABLE 2.   Market FOR Product, BY REGION, 2021-2030 (USD Million)

TABLE 3.   Market FOR Resting ECG Devices, BY REGION, 2021-2030 (USD Million)

TABLE 4.   Market FOR Stress ECG Devices, BY REGION, 2021-2030 (USD Million)

TABLE 5.   Market FOR Holter Monitors, BY REGION, 2021-2030 (USD Million)

TABLE 6.   Market FOR Implantable Loop Recorders, BY REGION, 2021-2030 (USD Million)

TABLE 7.   Market FOR Event Monitors, BY REGION, 2021-2030 (USD Million)

TABLE 8.   Market FOR MCT Devices, BY REGION, 2021-2030 (USD Million)

TABLE 9.   Market FOR Smart ECG Monitors, BY REGION, 2021-2030 (USD Million)

TABLE 10.   Market FOR Software and Service, BY REGION, 2021-2030 (USD Million)

TABLE 11.  Market, By End-User, 2021-2030 (USD Million)

TABLE 12.  Market FOR Hospitals & Clinics, BY REGION, 2021-2030 (USD Million)

TABLE 13.  Market FOR Home, BY REGION, 2021-2030 (USD Million)

TABLE 14.  Market FOR Ambulatory Care, BY REGION, 2021-2030 (USD Million)

TABLE 15.  Market, BY LEAD TYPE, 2021-2030 (USD Million)

TABLE 16.  Market FOR 12-lead, BY REGION, 2021-2030 (USD Million)

TABLE 17.  Market FOR 5-lead, BY REGION, 2021-2030 (USD Million)

TABLE 18.  Market FOR 3-lead, BY REGION, 2021-2030 (USD Million)

TABLE 19.  Market FOR 6-lead, BY REGION, 2021-2030 (USD Million)

TABLE 20.  Market FOR Single-lead, BY REGION, 2021-2030 (USD Million)

TABLE 21.  Market FOR Other Lead Types, BY REGION, 2021-2030 (USD Million)

TABLE 22.  Market, BY REGION, 2021-2030 (USD Million)

TABLE 23. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 24. NORTH AMERICA Market, By Product Type, 2021-2030 (USD Million)

TABLE 25. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million)

TABLE 26. NORTH AMERICA Market, BY LEAD TYPE, 2021-2030 (USD Million)

TABLE 27. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 28. EUROPE Market, By Product Type, 2021-2030 (USD Million)

TABLE 29. EUROPE Market, By End-User, 2021-2030 (USD Million)

TABLE 30. EUROPE Market, BY LEAD TYPE, 2021-2030 (USD Million)

TABLE 31. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 32. ASIA-PACIFIC Market, By Product Type, 2021-2030 (USD Million)

TABLE 33. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million)

TABLE 34. ASIA-PACIFIC Market, BY LEAD TYPE, 2021-2030 (USD Million)

TABLE 35. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 36. LAMEA Market, By Product Type, 2021-2030 (USD Million)

TABLE 37. LAMEA Market, By End-User, 2021-2030 (USD Million)

TABLE 38. LAMEA Market, BY LEAD TYPE, 2021-2030 (USD Million)

TABLE 39. GE Healthcare: COMPANY SNAPSHOT

TABLE 40. GE Healthcare: OPERATING SEGMENTS

TABLE 41. Nihon Kohden Corporation: COMPANY SNAPSHOT

TABLE 42. Nihon Kohden Corporation: OPERATING SEGMENTS

TABLE 43. Koninklijke Philips NV: COMPANY SNAPSHOT

TABLE 44. Koninklijke Philips NV: OPERATING SEGMENTS

TABLE 45. Medtronic: COMPANY SNAPSHOT

TABLE 46. Medtronic: OPERATING SEGMENTS

TABLE 47. Hill-Rom Holdings: COMPANY SNAPSHOT

TABLE 48. Hill-Rom Holdings: OPERATING SEGMENTS

TABLE 49. SCHILLER: COMPANY SNAPSHOT

TABLE 50. SCHILLER: OPERATING SEGMENTS

TABLE 51. BPL Medical Technologies: COMPANY SNAPSHOT

TABLE 52. BPL Medical Technologies: OPERATING SEGMENTS

TABLE 53. ACS Diagnostics: COMPANY SNAPSHOT

TABLE 54. ACS Diagnostics: OPERATING SEGMENTS

TABLE 55. BTL: COMPANY SNAPSHOT

TABLE 56. BTL: OPERATING SEGMENTS

TABLE 57. Ambu A/S: COMPANY SNAPSHOT

TABLE 58. Ambu A/S: OPERATING SEGMENTS

TABLE 59. Allengers Medical Systems, Ltd: COMPANY SNAPSHOT

TABLE 60. Allengers Medical Systems, Ltd: OPERATING SEGMENTS

TABLE 61. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS Co., Ltd: COMPANY SNAPSHOT

TABLE 62. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS Co., Ltd: OPERATING SEGMENTS

TABLE 63. FUKUDA DENSHI: COMPANY SNAPSHOT

TABLE 64. FUKUDA DENSHI: OPERATING SEGMENTS

TABLE 65. Innomed Medical: COMPANY SNAPSHOT

TABLE 66. Innomed Medical: OPERATING SEGMENTS

TABLE 67. Edan Instruments, Inc: COMPANY SNAPSHOT

TABLE 68. Edan Instruments, Inc: OPERATING SEGMENTS                

 TABLE 69. Cardioline SpA: COMPANY SNAPSHOT

TABLE 70. Cardioline SpA: OPERATING SEGMENTS                

TABLE 71. Eccosur: COMPANY SNAPSHOT

TABLE 72. Eccosur: OPERATING SEGMENTS                

TABLE 73. Suzuken Co. Ltd: COMPANY SNAPSHOT

TABLE 74. Suzuken Co. Ltd: OPERATING SEGMENTS                

TABLE 75. Norav Medical: COMPANY SNAPSHOT

TABLE 76. Norav Medical: OPERATING SEGMENTS                

TABLE 77. VectraCor, Inc: COMPANY SNAPSHOT

TABLE 78. VectraCor, Inc: OPERATING SEGMENTS                

TABLE 79. Bionet Co., Ltd: COMPANY SNAPSHOT

TABLE 80. Bionet Co., Ltd: OPERATING SEGMENTS                

TABLE 81. Nexus Lifecare: COMPANY SNAPSHOT

TABLE 82. Nexus Lifecare: OPERATING SEGMENTS                

TABLE 83. Midmark Corporation: COMPANY SNAPSHOT

TABLE 84. Midmark Corporation: OPERATING SEGMENTS                

TABLE 85. OSI Systems, Inc: COMPANY SNAPSHOT

TABLE 86. OSI Systems, Inc: OPERATING SEGMENTS                

 

List of Figures (22 Figures)

Figure 1 Diagnostic Electrocardiograph Market: Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries:  Market

Figure 4 Research Methodology: Hypothesis Building

Figure 5 Market: Product-Based Estimation

Figure 6 Top 24 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2020

Figure 8 Import Data for Diagnostic Electrocardiograph, By Country, 2016–2020 (USD Thousand)

Figure 9 Export Data for Diagnostic Electrocardiograph, By Country, 2016–2020 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 Market, By End-User, 2019 vs 2025 (USD Million)

Figure 12 Market Share, By Lead Type, 2019 vs 2025 (USD Million)

Figure 13 Market Share, By Product Type, 2019 vs 2025 (USD Million)

Figure 14 Geographical Snapshot of the Market

Figure 15 Resting ECG Devices to Witness Higher CAGR in Market for Product Type Segment during Forecast Period.

Figure 16 3-lead, 6-lead to Witness Higher CAGR in Market for Lead Type Segment during Forecast Period.

Figure 17 Hospitals & Clinics to Witness Higher CAGR in the Market for End-User Segment during Forecast Period.

Figure 18 North America Region Accounted for the Largest Share of the Market, By Regional Basis, in 2019

Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges

Figure 20 North America:  Market Snapshot

Figure 21 Asia Pacific:  Market Snapshot

Figure 22 Vendor Dive: Evaluation Overview

.

Market Segmentation

The global diagnostic ECG market is segmented by product type, lead type, and end use.

By Product Type

  • Holter Monitors
  • Resting ECG Systems
  • Stress ECG Monitors

In 2014, Holter monitors represented the largest segment, driven by the expansion of hospital networks and increased hospital expenditure on ECG devices.

By Lead Type

  • Single-lead ECG Devices
  • 3–6 Lead ECG Devices
  • 12-lead ECG Devices
  • Other Lead Types

In 2014, the 3–6 lead ECG devices segment dominated the market, attributed to their high efficiency at relatively low cost, and is expected to maintain a strong growth trajectory.

By End Use

  • Hospitals
  • Clinics
  • Ambulatory Settings
  • Other Institutions

In 2014, the hospital segment led the market, supported by the rapid increase in hospital establishments and significant capital allocation for ECG equipment.